Real World App-based CCAAP Management of Children With Asthma
Evaluation of App-based Management of Children's Asthma Based on Real World Data and Randomized Control Trial
1 other identifier
interventional
400
0 countries
N/A
Brief Summary
This study is a multi-center randomized controlled trial of children with asthma. The objective of the study is to compare the App-based efficacy of China Children Asthma Action Plan (CCAAP) and written CCAAP used in management of children with asthma. The main questions are:1. Is the App-based CCAAP effective/feasible in management of children with asthma? 2. Is the App-based CCAAP better than written CCAAP in management of children with asthma?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable asthma
Started Nov 2023
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 18, 2023
CompletedFirst Posted
Study publicly available on registry
November 1, 2023
CompletedStudy Start
First participant enrolled
November 25, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedNovember 1, 2023
October 1, 2023
1.1 years
September 18, 2023
October 31, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
number of asthma exacerbation
unscheduled clinics, emergency visiting, hospitalization, absent of school
12 months
Study Arms (2)
App-based CCAAP
OTHERPatients in this group will be provided App-based CCAAP to remind them take medicine regularly and direct them what to do when asthma get worse.
written CCAAP
OTHERPatients in this group will be provided written asthma action plan and direct them what to do when asthma get worse.
Interventions
App-based CCAAP, could remind patients take controller and reliever when asthma symptoms get worse through mobile.
Written CCAAP, conventional management for patients with asthma, remind them take controller and reliever when asthma symptoms get worse.
Eligibility Criteria
You may qualify if:
- did not receive control treatment or did not reach well-control;
- can perform spirometry pulmonary function tests;
- parents are skilled in using smartphones and APP apps (Android or IOS);
You may not qualify if:
- reach the level of asthma well control;
- can not use the smartphone APP software;
- can not cooperate the test of peak expiratory flow;
- did not treatment coexist respiratory disease effectively (such as sinusitis, obstructive sleep apnea-hypopnea syndrome, etc.);
- combined with other systemic diseases outside the respiratory system (such as leukemia, rheumatoid arthritis, etc.).
- receiving allergen-specific immunotherapy.
- undergoing trial for other medications or instruments.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maigeng Zhou
Center of Diseases Control and Prevention, China
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 18, 2023
First Posted
November 1, 2023
Study Start
November 25, 2023
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
November 1, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share